What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Which Robo Advisor Outperformed In 2026 highlights top performers and the tactics behind their gains, plus notes on risk and diversification.
24,805 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A bold 17-inch Wimbledon hat by a global star sparked more than fashion chatter — it raised real questions about cost...
When a shopper’s card data is compromised, banks often trigger rapid fraud alerts. This article breaks down how those...
The June CPI report showed a 0.4% month-over-month decline, boosting Bitcoin and other risk assets. BTC briefly touch...
AI hardware competition now hinges on storage alongside compute. NVIDIA drives data-center growth, while SanDisk ride...
If Rivian hits the sweet spot with the R2, the stock story could change in meaningful ways. This guide breaks down wh...
Two leading firms cut Microsoft price targets ahead of fiscal Q4, but both retain bullish ratings as Copilot and Azur...
A shadowy hosting network in Russia reportedly kept cybercrime online, driving millions in losses. This guide explain...
The auto industry is changing fast, and big, cash-rich automakers may be overlooked. This guide explains why investor...
A cyberattack compromised airbnb brian chesky’s account on X this week, circulating AI-driven posts about real-world ...
Investors are watching the S&P 500 with caution. A high CAPE reading can signal long-term risks, but smart planning—s...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...